US 8377945
Small molecule inhibitors of spleen tyrosine kinase (SYK)
granted A61PA61P1/00A61P1/04
Quick answer
US patent 8377945 (Small molecule inhibitors of spleen tyrosine kinase (SYK)) held by Rigel Pharmaceuticals, Inc. expires Mon Feb 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Feb 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61P, A61P1/00, A61P1/04, A61P1/16, A61P11/02